Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating)'s share price traded down 6.4% during trading on Tuesday . The stock traded as low as $0.98 and last traded at $1.02. 300,374 shares traded hands during trading, a decline of 91% from the average session volume of 3,483,830 shares. The stock had previously closed at $1.09.
Bright Minds Biosciences Stock Down 6.4 %
The company's 50 day moving average price is $1.03 and its 200-day moving average price is $1.14.
Get Bright Minds Biosciences alerts:Hedge Funds Weigh In On Bright Minds Biosciences
An institutional investor recently bought a new position in Bright Minds Biosciences stock. Jane Street Group LLC bought a new position in Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 24,701 shares of the company's stock, valued at approximately $37,000. Jane Street Group LLC owned approximately 0.21% of Bright Minds Biosciences at the end of the most recent reporting period. Institutional investors own 4.03% of the company's stock.
Bright Minds Biosciences Company Profile
(Get Rating)Bright Minds Biosciences Inc, a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
Featured Articles
- Get a free copy of the StockNews.com research report on Bright Minds Biosciences (DRUG)
- Ulta Issues A Beautiful FY Outlook, But Is the Stock A Buy Now?
- Should The Bancorp Make Your Small-Cap Watchlist for 2023?
- 3 Consumer Cyclical Stocks With Good Momentum
- Could Pinduoduo Be the Best Chinese Stock to Own?
- 3 Big Box Retail Bets for the Holidays
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.